Weight-Loss Surgery Benefits Blood Pressure Management
By Lori Solomon HealthDay Reporter
TUESDAY, Sept. 10, 2024 -- Bariatric surgery emerges as a durable solution for obesity-related hypertension, according to a study presented at the American Heart Association Hypertension Scientific Sessions 2024, held from Sept. 5 to 8 in Chicago.
Sneha Annie Sebastian, M.D., from Azeezia Medical College in Kerala, India, and a residency candidate from Alberta, Canada, and colleagues synthesized findings from 18 pivotal randomized controlled trials (1,386 patients with obesity) to evaluate the long-term effects of bariatric surgery on hypertension in individuals with obesity compared to medical or lifestyle management.
The researchers found that in a pooled analysis, there was a statistically significant difference in the rate of hypertension remission between patients who underwent bariatric surgery versus patients on medical or lifestyle management (risk ratio [RR], 2.77; 95 percent confidence interval [CI], 1.26 to 6.10). Relatedly, there was a substantial reduction in the use of antihypertensive medications while maintaining controlled blood pressure (RR, 7.10; 95 percent CI, 4.38 to 11.51), with no heterogeneity among findings. There were also significant improvements in systolic blood pressure control associated with bariatric surgery.
"Bariatric surgery is an effective solution for managing obesity-related hypertension," Sebastian said in a statement. "Future research should focus on conducting randomized controlled trials with long-term follow-up and large sample sizes, with a specific emphasis on hypertension outcomes, as many currently focus on diabetes outcomes."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
Few Adolescents With Obesity Prescribed Obesity Medications
FRIDAY, June 13, 2025 -- Despite an increase in the prevalence of prescribing, only 0.5 percent of U.S. adolescents with obesity were prescribed an obesity medication in 2023...
Real-World Weight Loss With Semaglutide, Tirzepatide Less Than That Seen in Clinical Trials
THURSDAY, June 12, 2025 -- For patients with obesity initiating pharmacotherapy with semaglutide or tirzepatide, weight loss at one year is 8.7 percent on average, which is lower...
Adherence to Healthy Diet Improves Cardiometabolic Risk, Even Without Weight Loss
WEDNESDAY, June 11, 2025 -- A healthy diet improves cardiometabolic risk factors, even if not associated with weight loss (WL), according to a study published online June 5...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.